Meakins Christie Laboratories, McGill University, Montreal, Que., Canada.
Respiration. 2012;84(1):4-11. doi: 10.1159/000339550. Epub 2012 Jun 29.
Asthma is a lung disease characterized by inflammation and remodeling of the airways. It is now widely accepted that airway inflammation and remodeling occur not only in the central airways but also in the small airways and even in the lung parenchyma. Inflammation of the distal lung can be observed even in mild asthmatics with normal or noncompromised lung function. Moreover, the small airways and the lung parenchyma can produce many Th2 cytokines and chemokines involved in initiation and perpetuation of the inflammatory process. In addition, the distal parts of the bronchial tree have been recognized as a predominant site of airflow obstruction in many asthmatics. In fact, the inflammation at this distal site has been described as more severe when compared to the large airway inflammation, and evidence of remodeling in the lung periphery is emerging. Recognition of asthma as a disease of the entire respiratory tract has an important clinical significance, highlighting the need to also consider the distal lung as a target in any therapeutic strategy for effective treatment of this disease.
哮喘是一种以气道炎症和重塑为特征的肺部疾病。现在人们普遍认为,气道炎症和重塑不仅发生在中央气道,也发生在小气道,甚至肺实质中。即使在肺功能正常或不受影响的轻度哮喘患者中,也可以观察到远端肺部的炎症。此外,小气道和肺实质可以产生许多参与炎症过程启动和持续的 Th2 细胞因子和趋化因子。此外,支气管树的远端部分已被认为是许多哮喘患者气流阻塞的主要部位。事实上,与大气道炎症相比,远端部位的炎症更为严重,并且肺周围组织重塑的证据也在不断出现。将哮喘视为整个呼吸道疾病具有重要的临床意义,强调需要将远端肺部也视为任何治疗策略的目标,以有效治疗这种疾病。